The result was announced on Saturday, 27 July 2019.

Meanwhile, the S&P BSE Sensex was up by 75.79 points or 0.19% to 37,807.83.

On the BSE, 2717 shares were traded in the counter so far compared with average daily volumes of 2133 shares in the past two weeks. The stock had hit a high of Rs 425.1 and a low of Rs 400.55. The stock hit a 52-week high of Rs 798.8 on 27 August 2018 and a 52-week low of Rs 390 on 24 July 2019.

The company's consolidated earnings before interest tax depreciation and amortization (EBITDA) increased 18% to Rs 104.5 crore in Q1 June 2019 over Q1 June 2018.

The consolidated EBITDA margin rose to 38.1% from 35.3% in Q1 June 2019 over Q1 June 2018.

Eris Lifesciences is engaged in developing, manufacturing and commercializing branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.